HUSSAIN IQBAL J — SEC Form 4 filings
SEC reporting owner CIK 1862050. 21 Form 4 filings on record with FilingPulse; latest filed 2026-06-24.
Transaction summary — filings shown
Covers all 21 filings on record, filed 2024-02-02 to 2026-06-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 18 legs across 14 filings — 223,666 shares, $4,282,830 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 53.
- Largest priced transaction: sale of 77,705 shares @ $16.39 ($1,273,756) in Centessa Pharmaceuticals plc, filed 2024-12-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Centessa Pharmaceuticals plc (CNTA) | Chief Legal Officer | 21 | — | 18 legs · 223,666 sh · $4,282,830 | 53 |
Form 4 filings — HUSSAIN IQBAL J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-24 | 4 | Centessa Pharmaceuticals plc (CNTA) | Disposition to issuer (D): 117,645 · Disposition to issuer (D): 5,500 · Disposition to issuer (D): 221,559 (derivative) · Disposition to issuer (D): 166,779 (derivative) · Disposition to issuer (D): 100,000 (derivative) · Disposition to issuer (D): 160,000 (derivative) · +4 more | EDGAR |
| 2026-02-03 | 4 | Centessa Pharmaceuticals plc (CNTA) | Sale (S): 1,010 @ $25.01 · Tax withholding (F): 7,780 @ $24.57 · Sale (S): 38,951 @ $25.15 · Grant/award (A): 40,000 @ $0 · Grant/award (A): 20,000 @ $0 · Grant/award (A): 160,000 (derivative) @ $0 | EDGAR |
| 2025-11-18 | 4 | Centessa Pharmaceuticals plc (CNTA) | Option exercise (M): 6,000 @ $5.84 · Sale (S): 6,000 @ $27.64 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2025-10-16 | 4 | Centessa Pharmaceuticals plc (CNTA) | Option exercise (M): 6,000 @ $5.84 · Sale (S): 6,000 @ $22.41 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2025-09-15 | 4 | Centessa Pharmaceuticals plc (CNTA) | Option exercise (M): 6,000 @ $5.84 · Sale (S): 6,000 @ $21.85 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2025-09-11 | 4 | Centessa Pharmaceuticals plc (CNTA) | Option exercise (M): 20,000 @ $5.84 · Sale (S): 20,000 @ $20.01 · Option exercise (M): 20,000 @ $5.84 · Sale (S): 20,000 @ $22 · Option exercise (M): 20,000 (derivative) @ $0 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2025-08-15 | 4 | Centessa Pharmaceuticals plc (CNTA) | Option exercise (M): 6,000 @ $5.84 · Sale (S): 6,000 @ $17.23 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2025-07-17 | 4 | Centessa Pharmaceuticals plc (CNTA) | Option exercise (M): 6,000 @ $5.84 · Sale (S): 6,000 @ $14.93 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2025-06-25 | 4 | Centessa Pharmaceuticals plc (CNTA) | Option exercise (M): 12,000 @ $5.84 · Sale (S): 12,000 @ $14.02 · Option exercise (M): 12,000 (derivative) @ $0 | EDGAR |
| 2025-05-02 | 4 | Centessa Pharmaceuticals plc (CNTA) | Option exercise (M): 311 @ $5.84 · Sale (S): 311 @ $14 · Option exercise (M): 311 (derivative) @ $0 | EDGAR |
| 2025-04-29 | 4 | Centessa Pharmaceuticals plc (CNTA) | Option exercise (M): 3,609 @ $5.84 · Sale (S): 3,609 @ $14.00 · Option exercise (M): 2,080 @ $5.84 · Sale (S): 2,080 @ $14.01 · Option exercise (M): 3,609 (derivative) @ $0 · Option exercise (M): 2,080 (derivative) @ $0 | EDGAR |
| 2025-03-19 | 4 | Centessa Pharmaceuticals plc (CNTA) | Option exercise (M): 6,000 @ $5.84 · Sale (S): 6,000 @ $16.45 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | Centessa Pharmaceuticals plc (CNTA) | Option exercise (M): 6,000 @ $5.84 · Sale (S): 4,612 @ $15.91 · Sale (S): 1,388 @ $17.05 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | Centessa Pharmaceuticals plc (CNTA) | Tax withholding (F): 12,879 @ $16.92 · Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
| 2025-01-17 | 4 | Centessa Pharmaceuticals plc (CNTA) | Option exercise (M): 6,000 @ $5.84 · Sale (S): 6,000 @ $15.29 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2024-12-31 | 4 | Centessa Pharmaceuticals plc (CNTA) | Tax withholding (F): 7,520 @ $16.35 | EDGAR |
| 2024-12-17 | 4 | Centessa Pharmaceuticals plc (CNTA) | Option exercise (M): 6,000 @ $5.84 · Sale (S): 77,705 @ $16.39 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2024-10-02 | 4 | Centessa Pharmaceuticals plc (CNTA) | Tax withholding (F): 7,520 @ $15.79 | EDGAR |
| 2024-07-02 | 4 | Centessa Pharmaceuticals plc (CNTA) | Tax withholding (F): 7,520 @ $9.03 | EDGAR |
| 2024-04-02 | 4 | Centessa Pharmaceuticals plc (CNTA) | Tax withholding (F): 7,520 @ $11.30 | EDGAR |
| 2024-02-02 | 4 | Centessa Pharmaceuticals plc (CNTA) | Grant/award (A): 42,500 @ $0 · Tax withholding (F): 7,885 @ $8.19 · Grant/award (A): 170,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1862050 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →